Intended for healthcare professionals

Letters Non-alcoholic fatty liver disease and cardiovascular risk

Studies on non-alcoholic fatty liver disease should stratify by disease severity

BMJ 2019; 367 doi: https://doi.org/10.1136/bmj.l6495 (Published 22 November 2019) Cite this as: BMJ 2019;367:l6495
  1. Matthew T McKenna-Barry, registrar,
  2. John D Ryan, consultant hepatologist
  1. Hepatology Unit, Beaumont Hospital / Royal College of Surgeons in Ireland, Dublin 9, Republic of Ireland
  1. matthewmckennabarry{at}beaumont.ie

In a large, population based cohort study, Alexander and colleagues report that a diagnosis of non-alcoholic fatty liver disease (NAFLD) does not confer an increased risk of ischaemic heart disease or stroke.1 To translate these findings into clinical practice, we must appreciate the spectrum of NAFLD severity, especially as patients with advanced fibrosis have …

View Full Text

Log in

Log in through your institution

Subscribe

* For online subscription